Oscar Health, Inc.
OSCR · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9 | $6 | $4 | $2 |
| % Growth | 56.5% | 42.1% | 114.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $9 | $6 | $4 | $2 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $1 | $1 | $0 |
| SG&A Expenses | $2 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7 | $5 | $3 | $2 |
| Operating Expenses | $9 | $6 | $5 | $2 |
| Operating Income | $0 | -$0 | -$1 | -$1 |
| % Margin | 0.4% | -4.6% | -14.8% | -29.7% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | -$0 | -$1 | -$1 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | $0 | -$0 | -$1 | -$1 |
| % Margin | 0.3% | -4.6% | -14.7% | -29.8% |
| EPS | 0.11 | -1.22 | -2.87 | -3.19 |
| % Growth | 109% | 57.5% | 10% | – |
| EPS Diluted | 0.096 | -1.22 | -2.87 | -3.19 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | -$1 | -$1 |
| % Margin | 1% | -3.6% | -13.9% | -28.7% |